Adhoc News

18.12.2023
Ad-hoc: Marinomed Biotech AG evaluates strategic options for Carragelose portfolio

Adhoc-Announcement

19.05.2022
Marinomed Biotech AG enters into license agreement with Procter & Gamble on CarrageloseĀ® products

Adhoc-Announcement

04.10.2021
Marinomed Biotech AG signs financing agreement with Nice & Green S.A. to advance its scientific and clinical programs

Adhoc-Announcement

19.02.2021
Marinomed Biotech AG shares positive clinical trial results for iota-carrageenan nasal spray in the prevention of COVID-19

Adhoc-Announcement

Lucia Ziegler, MSc
Head of Investor & Public Relations
Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg, Austria
+43 2262 90300
office@marinomed.com